• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于将小干扰RNA(siRNA)递送至人原代黑素细胞的超可变形阳离子脂质体。

Ultradeformable cationic liposomes for delivery of small interfering RNA (siRNA) into human primary melanocytes.

作者信息

Geusens B, Lambert J, De Smedt S C, Buyens K, Sanders N N, Van Gele M

机构信息

Department of Dermatology, Ghent University Hospital, Belgium.

出版信息

J Control Release. 2009 Feb 10;133(3):214-20. doi: 10.1016/j.jconrel.2008.10.003. Epub 2008 Oct 17.

DOI:10.1016/j.jconrel.2008.10.003
PMID:18973779
Abstract

The aim of this work was to develop a system that can deliver siRNA into cells present in the human epidermis. More specifically, we wanted to block the expression of a specific Myosin Va exon F containing isoform that is physiologically involved in melanosome transport in human melanocytes. Therefore, we prepared and investigated the capacity of ultradeformable cationic liposomes (UCLs) to deliver siRNA in hard-to-transfect human primary melanocytes. UCLs were formulated from different w:w ratios (6:1, 8:1 and 10:1) of the cationic lipid 1,2-dioleoyl-3-trimethylammonium propane (DOTAP) and the edge activator sodium cholate. Subsequently, UCL/siRNA complexes were prepared and their particle size, surface charge, deformability, cytotoxicity, transfection efficiency and long-term stability were tested. The best results were obtained with UCLs composed of a DOTAP/NaChol ratio of 6:1 (w:w) which are promising for future in vivo experiments.

摘要

这项工作的目的是开发一种能够将小干扰RNA(siRNA)递送至人表皮细胞的系统。更具体地说,我们想要阻断一种特定的含肌球蛋白Va外显子F的异构体的表达,该异构体在生理上参与人黑素细胞中黑素小体的转运。因此,我们制备并研究了超可变形阳离子脂质体(UCLs)在难以转染的人原代黑素细胞中递送siRNA的能力。UCLs由阳离子脂质1,2 - 二油酰基 - 3 - 三甲基铵丙烷(DOTAP)和边缘活化剂胆酸钠以不同的重量比(6:1、8:1和10:1)配制而成。随后,制备了UCL/siRNA复合物,并测试了它们的粒径、表面电荷、可变形性、细胞毒性、转染效率和长期稳定性。由DOTAP/NaChol比例为6:1(w:w)组成的UCLs取得了最佳结果,这对未来的体内实验很有前景。

相似文献

1
Ultradeformable cationic liposomes for delivery of small interfering RNA (siRNA) into human primary melanocytes.用于将小干扰RNA(siRNA)递送至人原代黑素细胞的超可变形阳离子脂质体。
J Control Release. 2009 Feb 10;133(3):214-20. doi: 10.1016/j.jconrel.2008.10.003. Epub 2008 Oct 17.
2
Knockdown of myosin Va isoforms by RNAi as a tool to block melanosome transport in primary human melanocytes.通过RNA干扰敲低肌球蛋白Va亚型作为阻断原代人黑素细胞中黑素小体运输的工具。
J Invest Dermatol. 2008 Oct;128(10):2474-84. doi: 10.1038/jid.2008.100. Epub 2008 Apr 10.
3
Efficient siRNA delivery using novel siRNA-loaded Bubble liposomes and ultrasound.新型载 siRNA 泡囊脂质体和超声联合高效传递 siRNA。
Int J Pharm. 2012 Jan 17;422(1-2):504-9. doi: 10.1016/j.ijpharm.2011.11.023. Epub 2011 Nov 22.
4
DOTAP functionalizing single-walled carbon nanotubes as non-viral vectors for efficient intracellular siRNA delivery.DOTAP 功能化单壁碳纳米管作为非病毒载体,用于高效的细胞内 siRNA 递送。
Drug Deliv. 2016;23(3):840-8. doi: 10.3109/10717544.2014.919542. Epub 2015 Sep 4.
5
Evaluation of cationic dendrimer and lipid as transfection reagents of short RNAs for stem cell modification.评价阳离子树状高分子和脂质作为转染试剂对干细胞修饰的短 RNA 效果。
Int J Pharm. 2013 May 1;448(1):231-8. doi: 10.1016/j.ijpharm.2013.03.035. Epub 2013 Mar 25.
6
Structure and gene silencing activities of monovalent and pentavalent cationic lipid vectors complexed with siRNA.与小干扰RNA(siRNA)复合的单价和五价阳离子脂质载体的结构及基因沉默活性
Biochemistry. 2007 Apr 24;46(16):4785-92. doi: 10.1021/bi062138l. Epub 2007 Mar 29.
7
The biological activity of cationic liposomes in drug delivery and toxicity test in animal models.阳离子脂质体在药物递送中的生物活性及在动物模型中的毒性测试。
Environ Toxicol Pharmacol. 2016 Oct;47:159-164. doi: 10.1016/j.etap.2016.09.015. Epub 2016 Sep 26.
8
siRNA delivery to lung-metastasized tumor by systemic injection with cationic liposomes.通过阳离子脂质体全身注射将小干扰RNA递送至肺转移瘤。
J Liposome Res. 2015;25(4):279-86. doi: 10.3109/08982104.2014.992024. Epub 2015 Sep 4.
9
siRNA delivery by a transferrin-associated lipid-based vector: a non-viral strategy to mediate gene silencing.通过转铁蛋白相关脂质载体递送小干扰RNA:一种介导基因沉默的非病毒策略。
J Gene Med. 2007 Mar;9(3):170-83. doi: 10.1002/jgm.1006.
10
In vitro and in vivo transfection efficiency of a novel ultradeformable cationic liposome.
Biomaterials. 2004 Jan;25(2):305-13. doi: 10.1016/s0142-9612(03)00534-9.

引用本文的文献

1
Transdermal delivery of ultradeformable cationic liposomes complexed with miR211-5p (UCL-211) stabilizes BRAFV600E+ melanocytic nevi.与miR211-5p复合的超可变形阳离子脂质体(UCL-211)的透皮递送可稳定BRAFV600E+黑素细胞痣。
J Control Release. 2025 May 10;381:113586. doi: 10.1016/j.jconrel.2025.113586. Epub 2025 Mar 1.
2
T14diLys/DOPE Liposomes: An Innovative Option for siRNA-Based Gene Knockdown?T14diLys/DOPE脂质体:基于小干扰RNA的基因敲低的创新选择?
Pharmaceutics. 2024 Dec 27;17(1):25. doi: 10.3390/pharmaceutics17010025.
3
Transdermal Delivery of Ultradeformable Cationic Liposomes Complexed with miR211-5p (UCL-211) Stabilizes BRAFV600E+ Melanocytic Nevi.
与miR211-5p复合的超可变形阳离子脂质体(UCL-211)的经皮递送可稳定BRAFV600E+黑素细胞痣。
bioRxiv. 2024 Oct 21:2024.10.17.618694. doi: 10.1101/2024.10.17.618694.
4
Palmitoylethanolamide-Incorporated Elastic Nano-Liposomes for Enhanced Transdermal Delivery and Anti-Inflammation.用于增强透皮给药和抗炎的载有棕榈酰乙醇胺的弹性纳米脂质体
Pharmaceutics. 2024 Jun 29;16(7):876. doi: 10.3390/pharmaceutics16070876.
5
Enhancing Gene Therapy through Ultradeformable Vesicles for Efficient siRNA Delivery.通过超可变形囊泡增强基因治疗以实现高效的小干扰RNA递送
Pharm Nanotechnol. 2025;13(1):55-69. doi: 10.2174/0122117385271654231215064542.
6
Design and development of topical liposomal formulations in a regulatory perspective.从监管角度设计和开发局部脂质体配方。
Drug Deliv Transl Res. 2022 Aug;12(8):1811-1828. doi: 10.1007/s13346-021-01089-z. Epub 2021 Nov 9.
7
Elastic and Ultradeformable Liposomes for Transdermal Delivery of Active Pharmaceutical Ingredients (APIs).弹性和超可变形脂质体用于经皮递送活性药物成分(APIs)。
Int J Mol Sci. 2021 Sep 9;22(18):9743. doi: 10.3390/ijms22189743.
8
A Comprehensive Review on Preparation, Evaluation and Applications of Deformable Liposomes.关于可变形脂质体的制备、评价及应用的综合综述
Iran J Pharm Res. 2021 Winter;20(1):186-205. doi: 10.22037/ijpr.2020.112878.13997.
9
Innovations in Biomaterial Design toward Successful RNA Interference Therapy for Cancer Treatment.生物材料设计的创新,实现癌症治疗的 RNA 干扰疗法的成功。
Adv Healthc Mater. 2021 Jul;10(13):e2100350. doi: 10.1002/adhm.202100350. Epub 2021 May 11.
10
Stability of Alkyl Chain-Mediated Lipid Anchoring in Liposomal Membranes.烷基链介导的脂质锚定在脂质体膜中的稳定性。
Cells. 2020 Sep 29;9(10):2213. doi: 10.3390/cells9102213.